Chemotherapy Combined With Bevacizumab Neoadjuvant Therapy for HER2-negative Breast Cancer
Status: RECRUITING
Study type: INTERVENTIONAL
Conditions: Solid Tumor
Interventions: DRUG: Bevacizumab
Sponsor: Hebei Medical University Fourth Hospital